➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Colorcon
Dow
Merck
Boehringer Ingelheim
Baxter
Moodys

Last Updated: August 5, 2020

DrugPatentWatch Database Preview

FLUORINE F-18 Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Which patents cover Fluorine F-18, and what generic alternatives are available?

Fluorine F-18 is a drug marketed by Ge Healthcare and is included in one NDA.

The generic ingredient in FLUORINE F-18 is sodium fluoride f-18. There are one thousand four hundred and seventy-two drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the sodium fluoride f-18 profile page.

US ANDA Litigation and Generic Entry Outlook for Fluorine F-18

A generic version of FLUORINE F-18 was approved as sodium fluoride f-18 by SOFIE on December 26th, 2012.

  Start Trial

Summary for FLUORINE F-18
Drug patent expirations by year for FLUORINE F-18
Recent Clinical Trials for FLUORINE F-18

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Cambridge University Hospitals NHS Foundation TrustPhase 4
Antaros Medical ABPhase 4
Center for Neurology, StockholmPhase 2

See all FLUORINE F-18 clinical trials

US Patents and Regulatory Information for FLUORINE F-18

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ge Healthcare FLUORINE F-18 sodium fluoride f-18 INJECTABLE;INTRAVENOUS 017042-001 Approved Prior to Jan 1, 1982 DISCN Yes No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Johnson and Johnson
Baxter
Merck
McKesson
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.